Idorsia has raised 330 million Swiss francs ($340.31 million) from a share offering, the Swiss drugmaker said on Wednesday, as it bolsters its coffers for the planned launch of an insomnia drug and for research and development.
from Reuters: New Issues News https://ift.tt/2LKJAtO
Tidak ada komentar:
Posting Komentar